Data Report
State of HealthTech & Biotech Funding 2026
Documented venture funding into HealthTech & Biotech companies — totals, the largest rounds, stage mix, and the quarterly trend.
Data as of September 2026 · Updated continuously · Figures in USD
$1.3T
Total Documented Funding
10,717
Funding Rounds
5,226
Companies Funded
$346.8B
Largest Round
Funding Trend
Documented capital raised per quarter. The current quarter is still filling in.
Peak quarter '26 Q2 at $386.0B. Latest complete quarter (2026Q2): ▲ 588% QoQ · ▲ 2066% YoY. Current quarter (QTD) is still filling in.
Largest Rounds
The biggest documented HealthTech & Biotech funding rounds. Tap any company for its full profile.
AprilBio
Corporate Round · South Korea
$346.8B
Jun 2026
NEX-I
Series B
$61.0B
Aug 2025
Elisigen
Series C
$42.0B
Unknown
IT Chem
Convertible Note · South Korea
$40.0B
Feb 2026
Ybiologics
Convertible Note
$35.0B
Aug 2025
ENCell
Series B · South Korea
$25.6B
Unknown
AbClon
Convertible Note · South Korea
$25.2B
Oct 2025
ENCell
Growth Equity · South Korea
$24.2B
Jun 2022
KANAPH Therapeutics
Series B · South Korea
$24.0B
Unknown
NEX-I
Series A
$22.0B
Unknown
Novorex
Venture Round · United States
$21.0B
Apr 2026
Cell in Cells
Series B · South Korea
$12.0B
Unknown
AbClon
Venture Round · South Korea
$10.8B
Oct 2025
ENCell
Series A · South Korea
$10.1B
Unknown
Epibiotech
Venture Round · South Korea
$10.0B
Sep 2021
Rounds by Stage
How documented rounds break down by funding stage.
Explore More
Methodology
Figures are aggregated from Indexed's live database of 100,049+ private companies and 22,293+ investors. Every funding round is sourced from a verifiable public record; duplicates are merged and only rounds meeting a confidence threshold are counted. Amounts are whole USD; undisclosed rounds are excluded from dollar totals but counted where noted. "Documented" means announced with a citable source — true market totals are higher. Data as of September 2026 and updated continuously. Free to cite with attribution to Indexed.